Cam Gallagher Zentalis Pharmaceuticals, Inc. (ZNTL) insider trading activity

ZNTL Quotes by TradingView

Cam Gallagher is President, Interim CFO of Zentalis Pharmaceuticals, Inc.. Currently has a direct ownership of 633,680 shares of ZNTL, which is worth approximately $2.41 Million. The most recent transaction as insider was on Dec 02, 2020, when has been sold 10,000 shares (Common Stock) at a price of $51.26 per share, resulting in proceeds of $512,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 634K
0% 3M change
36.72% 12M change
Total Value Held $2.41 Million

Cam Gallagher Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 02 2020
SELL
Open market or private sale
$512,600 $51.26 p/Share
10,000 Reduced 1.6%
616,931 Common Stock
Nov 23 2020
SELL
Open market or private sale
$468,700 $46.87 p/Share
10,000 Reduced 1.57%
626,931 Common Stock

Also insider at

OCUP
Ocuphire Pharma, Inc. Healthcare
CG

Cam Gallagher

President, Interim CFO
New York, NY

Track Institutional and Insider Activities on ZNTL

Follow Zentalis Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZNTL shares.

Notify only if

Insider Trading

Get notified when an Zentalis Pharmaceuticals, Inc. insider buys or sells ZNTL shares.

Notify only if

News

Receive news related to Zentalis Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ZNTL